newsGraft engineering sees potential to reduce GVHD risk in leukemia patients11 January 2022 | By European Pharmaceutical ReviewNew study shows risk of developing graft-versus-host disease (GVHD) in leukaemia patients reduced by removing naïve T cells from donor blood used for stem cell grafts.
newsDistributing HIV drugs using mobile vans increases viral suppression, finds study12 March 2020 | By Victoria Rees (European Pharmaceutical Review)Researchers have shown that using mobile vans to deliver and dispense HIV drugs in South Africa and Uganda helps to combat the disease.
newsSecond potential male birth control pill passes human safety tests3 April 2019 | By European Pharmaceutical ReviewThe experimental male birth control pill 11-beta-MNTDC - a modified testosterone that has the combined actions of a male hormone and a progesterone - passes human safety tests...
newsAbatacept improves survival in patients with acute GvHD11 December 2017 | By Dr Zara Kassam (European Pharmaceutical Review)A drug used to treat rheumatoid arthritis improves survival after hematopoietic stem cell transplant...
